Rocket


News + Filings
Transactions



GOLDFISCHER CARL

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
08/12/2022Epizyme, Inc.EPZMDispositionCommon Stock, par value $0.00019k$0.00$0 08/12/2022
08/12/2022Epizyme, Inc.EPZMDispositionCommon Stock, par value $0.00013.4M$0.00$0See Footnote08/12/2022
08/12/2022Epizyme, Inc.EPZMDispositionCommon Stock, par value $0.000113.1k$0.00$0 08/12/2022
06/14/2022Galecto, Inc.GLTOGrantStock Option (right to buy)36k$1.98$71.3k 06/14/2022
06/02/2022Enliven Therapeutics, Inc.IMRAGrantStock Options (Right to Buy)8.5k$1.07$9.1k 06/02/2022
05/17/2022Epizyme, Inc.EPZMGrantCommon Stock, par value $0.00019k$0.00$0 05/17/2022
05/17/2022Epizyme, Inc.EPZMGrantStock Option (Right to Buy)41k$0.56$23k 05/17/2022
11/17/2021Galecto, Inc.GLTOGrant 18k$3.23$58.1k 11/17/2021
06/29/2021Enliven Therapeutics, Inc.IMRAGrantStock Options (Right to Buy)7.7k$8.12$62.8k 06/29/2021
06/11/2021Epizyme, Inc.EPZMGrantStock Option (Right to Buy)40.6k$8.53$346k 06/11/2021
06/11/2021Epizyme, Inc.EPZMGrantCommon Stock, par value $0.00018.1k$0.00$0 06/11/2021
05/26/2021Galecto, Inc.GLTOGrantStock Option (right to buy)18k$4.93$88.7k 05/26/2021
11/11/2020Epizyme, Inc.EPZMPurchaseCommon Stock, par value $0.00015k$12.07$60.4k 11/11/2020
11/02/2020Galecto, Inc.GLTOConversionSeries C-3 Preferred Stock392.4k$0.00$0See footnote11/02/2020
11/02/2020Galecto, Inc.GLTOConversionSeries C-3 Preferred Stock7.5k$0.00$0See footnote11/02/2020
11/02/2020Galecto, Inc.GLTOConversionSeries D Preferred Stock3.7k$0.00$0 11/02/2020
11/02/2020Galecto, Inc.GLTOConversionCommon Stock9.6k$0.00$0 11/02/2020
11/02/2020Galecto, Inc.GLTOConversionCommon Stock1M$0.00$0See footnote11/02/2020
11/02/2020Galecto, Inc.GLTOConversionCommon Stock19.4k$0.00$0See footnote11/02/2020
09/25/2020Galecto, Inc.GLTOGrantSeries D Preferred Stock3.7k$27.11$100k 11/02/2020
05/29/2020Epizyme, Inc.EPZMGrantStock Option (Right to Buy)14k$17.55$245.9k 05/29/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionCommon Stock690.2k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionCommon Stock13.1k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries Seed Preferred Stock281.9k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries Seed Preferred Stock5.4k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries A Preferred Stock3.2M$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries A Preferred Stock61.4k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries B Preferred Stock845k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries B Preferred Stock16.1k$0.00$0By entities affiliated with Bay City Capital LLC03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAGrantStock Option (right to buy)15.5k$16.00$247.3kBy Bay City Capital LLC03/16/2020
05/31/2019Epizyme, Inc.EPZMGrantStock Option (Right to Buy)17.6k$13.74$242.3k 05/31/2019
02/07/2019CymaBay Therapeutics, Inc.CBAYSaleCommon Stock11.7k$9.02$105.3k 02/07/2019
02/07/2019CymaBay Therapeutics, Inc.CBAYExerciseStock Option (right to buy)2.3k$5.00$11.7k 02/07/2019
02/07/2019CymaBay Therapeutics, Inc.CBAYExerciseStock Option (right to buy)9.3k$5.50$51.4k 02/07/2019
01/29/2019CymaBay Therapeutics, Inc.CBAYGrantStock Option (right to buy)27.7k$8.43$233.6k 01/29/2019
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy